Company Filing History:
Years Active: 2003-2010
Title: Karen O'Rourke: Innovator in Regulating Apoptosis
Introduction
Karen O'Rourke is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of apoptosis regulation, holding a total of 3 patents. Her work focuses on innovative methods and compositions that have the potential to impact therapeutic approaches in cellular functions.
Latest Patents
O'Rourke's latest patents include groundbreaking inventions such as "Methods and compositions for regulating FAS-associated apoptosis." This invention introduces a novel protein designated FADD, along with FADD fragments and anti-FADD antibodies. These components are useful for modulating Fas-associated cellular functions, including apoptosis. Additionally, the patent provides nucleic acid molecules coding for these proteins and antibodies, as well as processes for creating these compositions. Another significant patent is also titled "Methods and compositions for regulating Fas-associated apoptosis," which details a purified mammalian protein designated FADD that binds to the cytoplasmic region of the Fas receptor. This patent further includes nucleic acid molecules that encode the mammalian protein and methods for utilizing these proteins and nucleic acid molecules.
Career Highlights
Karen O'Rourke is affiliated with the University of Michigan, where she continues her research and development in the field of apoptosis. Her work has garnered attention for its potential applications in diagnostics and therapeutics.
Collaborations
O'Rourke collaborates with notable professionals in her field, including Vishva M Dixit, enhancing the impact of her research through shared expertise and innovation.
Conclusion
Karen O'Rourke's contributions to the field of apoptosis regulation through her patents and research at the University of Michigan highlight her role as a leading inventor. Her innovative approaches have the potential to advance therapeutic methods significantly.